These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 13492363)

  • 1. [Experimental studies on the mode of action of cycloserine. II. The influences on glutamic-aspartic transamination].
    AOKI T
    Kekkaku; 1957 Oct; 32(10):544-6. PubMed ID: 13492363
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental studies on the mechanism of bacteriostatic action of isonicotinic acid hydrazid (INAH). I. On the influences of INAH on transaminase of BCG].
    SAKAI J
    Kekkaku; 1954 May; 29(5):161-5; English abstract, 189. PubMed ID: 13175307
    [No Abstract]   [Full Text] [Related]  

  • 3. [The mechanism of D-amination of mycobacterium tuberculosis avium. II. Transamination from D-amino acid].
    SAITO M
    Kekkaku; 1956 Jun; 31(6):329-32. PubMed ID: 13346847
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental findings on constitution and mode of action of a toxic lipid component of the tubercle bacillus.
    BLOCH H; NOLL H
    Trans Annu Meet Natl Tuberc Assoc; 1953; 49():94-7. PubMed ID: 13136292
    [No Abstract]   [Full Text] [Related]  

  • 5. [Processes of tissular transamination & pharmacological lesions due to radiomimetic substances. I. Hepatic & splenic aspartic glutamic transaminases].
    SALGARELLO G; MORATELLO R; MURARI G
    Boll Soc Ital Biol Sper; 1958 Nov; 34(22):1540-3. PubMed ID: 13607853
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of aspartic acid and glutamic acid hydrazides on Mycobacterium tuberculosis. I. Effect of aspartic acid hydrazide on Mycobacterium tuberculosis cultures].
    MASSALSKI W; ODRZYWOLSKA A; MIGDALSKA B; DABROWSKA H
    Gruzlica (1926); 1958 Nov; 26(11):919-26. PubMed ID: 13630439
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental studies of the antibacterial action of cycloserine].
    BESTA B; LUCCHESI M; ZUBIANI M
    Lotta Tuberc; 1957 Dec; 27(12):1222-4. PubMed ID: 13540297
    [No Abstract]   [Full Text] [Related]  

  • 8. [Processes of tissular transamination & pharmacological lesions due to radiomimetic substances. II. Hepatic & splenic glutamic pyruvic transaminases].
    SALGARELLO G; MURARI G; MORATELLO R
    Boll Soc Ital Biol Sper; 1958 Nov; 34(22):1543-5. PubMed ID: 13607854
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of metabolism in tuberculous lesions. II. Further studies on the N-acetyltyramine formation by Mycobacterium tuberculosis.
    SAKURAI H
    Acta Tuberc Jpn; 1956 Dec; 6(2):63-8. PubMed ID: 13444078
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aspartic acid-glutamic acid transaminase in Mycobacterium phlei].
    GASIOR E
    Acta Physiol Pol; 1957; 8(3-3a):331-2. PubMed ID: 13532790
    [No Abstract]   [Full Text] [Related]  

  • 11. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid.
    Zhang Y; Wade MM; Scorpio A; Zhang H; Sun Z
    J Antimicrob Chemother; 2003 Nov; 52(5):790-5. PubMed ID: 14563891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of action of cycloserine on Mycobacterium tuberculosis].
    VIALLIER J; CAYRE RM
    C R Seances Soc Biol Fil; 1957; 151(8-9):1545-8. PubMed ID: 13537479
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antibacterial action in vitro of cycloserine in discontinuous contact with human Mycobacterium tuberculosis].
    SEREMBE M
    G Ital Chemioter; 1957; 4(3-4):522-6. PubMed ID: 13562599
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental studies on the mode of action of cycloserine. I. Effects on glutamic acid decarboxylation].
    AOKI T
    Kekkaku; 1957 Aug; 32(8):418-21. PubMed ID: 13482093
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aminoacids metabolism of tubercle bacillus. II. Studies on the asparaginase].
    KATAYAMA T; TANAKA S; AOKI K
    Kekkaku; 1954 Dec; 29(12):472-6; English summary, 510-1. PubMed ID: 14354786
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental studies on the mode of action of cycloserine. 3. Influences on indol formation].
    AOKI T
    Kekkaku; 1957 Nov; 32(11):605-8; English abstract 644. PubMed ID: 13492371
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies of metabolism in tuberculous lesions. III. Further studies on the decomposition of tyrosine-derivatives by Mycobacterium tuberculosis.
    SAKURAI H
    Acta Tuberc Jpn; 1958 Dec; 8(1-2):32-8. PubMed ID: 13660902
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the peroxidase of Mycobacterium tuberculosis].
    TOMODA T
    Kekkaku; 1958 Oct; 33(10):674-8; English abstract 705. PubMed ID: 13611841
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biochemical and genetic studies on nucleic acids extracted from streptomycin resistant avian tubercle bacilli. II].
    SASAKI T
    Kekkaku; 1957 Oct; 32(10):572-4. PubMed ID: 13492369
    [No Abstract]   [Full Text] [Related]  

  • 20. The structure of a resuscitation-promoting factor domain from Mycobacterium tuberculosis shows homology to lysozymes.
    Cohen-Gonsaud M; Barthe P; Bagnéris C; Henderson B; Ward J; Roumestand C; Keep NH
    Nat Struct Mol Biol; 2005 Mar; 12(3):270-3. PubMed ID: 15723078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.